Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy in young patients with newly diagnosed high-risk B-ALL and Ph-like mutations; study is completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-acute Lymphoblastic Leukemia
• Central Nervous System Leukemia
• Testicular Leukemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | Phase 3 | Status: COMPLETED | Results posted: 2024-03-12